This article was originally published in The Gray Sheet
Enter into letter of intent to jointly develop, manufacture and market MedSonic's STAR ultrasonic cavitation angioplasty system. Under the agreement, Meadox, which manufactures vascular devices and diagnostics, "would acquire an equity interest" in the ultrasound product developer ("The Gray Sheet" Oct. 5, 1992, In Brief).
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.